Comments

Verastem Stock Price, Quotes and Forecasts

Q: What sector and industry does Verastem (VSTM) operate in?

Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VSTMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$6.19

-0.54-8.02%

At close: -

$6.19

0.000.00%

After Hours: Mar 28, 4:00 PM EDT

Verastem (VSTM) Forecast

News Earnings Verastem (VSTM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Verastem Stock Price, Quotes and Forecasts | NASDAQ:VSTM | Benzinga

Explore Verastem stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VSTM.

Open	$6.70
Close	$6.19
Volume / Avg.	811.06K / 1.34M
Day Range	$6.11 - $6.72
52 Wk Range	2.10 - 13.52
Market Cap	$318.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	14.26%
Days to Cover	5.78

Recent News

Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Is Cancer-Focused Verastem Oncology Stock Trading Higher On Tuesday?

Verastem seeks FDA approval for avutometinib in recurrent LGSOC based on trial results, with a decision expected by June 2025.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$6.70
Close	$6.19
Volume / Avg.	811.06K / 1.34M
Day Range	$6.11 - $6.72
52 Wk Range	2.10 - 13.52
Market Cap	$318.70M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	14.26%
Days to Cover	5.78

About Verastem Inc

Sector

Health Care

Industry

Biotechnology

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicin...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Verastem (VSTM) stock?

You can purchase shares of Verastem (NASDAQ:VSTM) through any online brokerage.

View our list of the best stock brokerages

Who are Verastem (VSTM) competitors?

Other companies in Verastem’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).

What is the forecast, or price target, for Verastem (VSTM) stock?

Verastem has a consensus price target of $15.70.

What is the current price for Verastem (VSTM)?

The stock price for Verastem (NASDAQ: VSTM) is $6.19 last updated March 28, 2025 at 4:00 PM EDT.

Does Verastem (VSTM) pay a dividend?

There are no upcoming dividends for Verastem.

When is Verastem (NASDAQ:VSTM) reporting earnings?

Verastem’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Verastem (VSTM) going to split?

There is no upcoming split for Verastem.

What sector and industry does Verastem (VSTM) operate in?

Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.